Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Fenwick
Rema Saxena
Janice M Harper

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Dialysis: when to start or when to stop?Sean Fenwick, Rema Saxena, Janice M Harper
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|August 30, 2008
Intravenous iron administration in a short-stay hospital settingGeorge Peebles, Sean Fenwick
NDT Plus|May 8, 2015
The combined use of sirolimus and cyclosporin in the management of refractory minimal change nephropathy: 'a novel use of sirolimus'Rachel Davison, Sean Fenwick
Journal of Renal Care|February 4, 2011
Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysisSean Fenwick, George Peebles
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
Aldactone therapy in a peritoneal dialysis patientSean Fenwick, Gordon M Bell
Kidney Medicine|December 8, 2025
Anti-GBM Disease Following Ovarian Mesonephric-Like Adenocarcinoma: A Unique Insight Into Paraneoplastic AutoimmunityThomas Fairhead, Sophie Seager, Jennifer Whitehead, et al.
Clinical Kidney Journal|June 9, 2016
A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysisLindsey Kilshaw, Hannah Sammut, Rebecca Asher, et al.
Annals of Clinical Biochemistry|April 15, 2005
In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoringSean Fenwick, Edward A Roberts, Balakrishna S Mahesh, et al.
NDT Plus|May 8, 2015
The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney diseaseSmeeta Sinha, Diana Y Y Chiu, George Peebles, et al.
Journal of Renal Care|May 13, 2009
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney diseaseSmeeta Sinha, Diana Y Y Chiu, George Peebles, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Dialysis: when to start or when to stop?Sean Fenwick, Rema Saxena, Janice M Harper
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|August 30, 2008
Intravenous iron administration in a short-stay hospital settingGeorge Peebles, Sean Fenwick
NDT Plus|May 8, 2015
The combined use of sirolimus and cyclosporin in the management of refractory minimal change nephropathy: 'a novel use of sirolimus'Rachel Davison, Sean Fenwick
Journal of Renal Care|February 4, 2011
Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysisSean Fenwick, George Peebles
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
Aldactone therapy in a peritoneal dialysis patientSean Fenwick, Gordon M Bell
Kidney Medicine|December 8, 2025
Anti-GBM Disease Following Ovarian Mesonephric-Like Adenocarcinoma: A Unique Insight Into Paraneoplastic AutoimmunityThomas Fairhead, Sophie Seager, Jennifer Whitehead, et al.
Clinical Kidney Journal|June 9, 2016
A study to describe the health trajectory of patients with advanced renal disease who choose not to receive dialysisLindsey Kilshaw, Hannah Sammut, Rebecca Asher, et al.
Annals of Clinical Biochemistry|April 15, 2005
In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoringSean Fenwick, Edward A Roberts, Balakrishna S Mahesh, et al.
NDT Plus|May 8, 2015
The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney diseaseSmeeta Sinha, Diana Y Y Chiu, George Peebles, et al.
Journal of Renal Care|May 13, 2009
Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney diseaseSmeeta Sinha, Diana Y Y Chiu, George Peebles, et al.
Pageof 2